Most sold healthcare stocks in Q1 2014

See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2014, measured as net reductions in reported share positions from Q4 2013 into Q1 2014. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), REVVITY INC (RVTY), DANAHER CORP (DHR). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
PFEPFIZER INC-10,354,123$9.46M045111
MRKMERCK & CO. INC.-8,516,584-$139.19K126112
RVTYREVVITY INC-5,331,114-$218.57K01031
DHRDANAHER CORP-4,816,039-$375.55K12124
BSXBOSTON SCIENTIFIC CORP-3,578,515$27.06K00202
ZTSZOETIS INC-3,481,985-$129.22K01203
ABTABBOTT LABORATORIES-3,353,458-$122.63K05229
AAGILENT TECHNOLOGIES INC-3,038,886-$178.53K01223
HCAHCA HEALTHCARE INC-2,654,617-$126.65K00010
JNJJOHNSON & JOHNSON-2,465,279-$63.15K093218
MASIMASIMO CORP-2,153,144-$62.94K00010
LLYELI LILLY & CO-1,817,253-$45.32K00405
PHGKONINKLIJKE PHILIPS NVR- NY-1,734,960-$116.98K01203
TMOTHERMO FISHER SCIENTIFIC INC-1,684,820-$36.22K10709
MCKMCKESSON CORP-1,306,974-$210.95K00020
AZNASTRAZENECA PLC-SPONS ADR-1,286,400-$68.42K00102
WATWATERS CORP-1,170,643-$99.63K01203
GILDGILEAD SCIENCES INC-1,066,107-$103.28K16119
CORTCORCEPT THERAPEUTICS INC-991,978-$3.19K00010
CCRNCROSS COUNTRY HEALTHCARE INC-897,224-$5.50K01011
HUMHUMANA INC-780,193-$79.14K10011
EXELEXELIXIS INC-773,300-$5.78K00101
DVADAVITA INC-641,289$216.32K03306
SYKSTRYKER CORP-614,565$42.55K01314
RMDRESMED INC-605,000-$30.96K00103
CRLCHARLES RIVER LABORATORIES-573,246-$9.29K01203
AMGNAMGEN INC-567,617-$60.58K01214
NVSNOVARTIS AG-SPONSORED ADR-454,902$386.42K04409
SGMOSANGAMO THERAPEUTICS INC-447,550-$4.54K00101
MOHMOLINA HEALTHCARE INC-415,282-$14.25K00101
EWEDWARDS LIFESCIENCES CORP-404,413-$7.44K00111
CHECHEMED CORP-387,767-$13.39K20204
CYHCOMMUNITY HEALTH SYSTEMS INC-384,800-$15.11K00010
CAHCARDINAL HEALTH INC-371,347-$19.25K01113
PBHPRESTIGE CONSUMER HEALTHCARE-337,575-$21.73K01011
FOLDAMICUS THERAPEUTICS INC-278,401-$68900101
BMRNBIOMARIN PHARMACEUTICAL INC-215,266-$15.28K10011
DGXQUEST DIAGNOSTICS INC-206,804-$5.04K03104
ARAYACCURAY INC-199,883-$1.52K00101
ISRGINTUITIVE SURGICAL INC-184,362-$55.65K00303
DXCMDEXCOM INC-176,700-$3.99K00101
UHSUNIVERSAL HEALTH SERVICES-B-168,291-$11.37K10102
GMEDGLOBUS MEDICAL INC - A-153,882-$1.61K00202
BIIBBIOGEN INC-149,547-$31.33K11013
FONRFONAR CORP-148,800-$4.53K00101
CYTKCYTOKINETICS INC-147,200-$39200101
ANGOANGIODYNAMICS INC-118,500-$2.13K00101
MDXGMIMEDX GROUP INC-100,350-$87700010
RGENREPLIGEN CORP-97,407-$1.69K00101
AMNAMN HEALTHCARE SERVICES INC-96,800-$1.64K00101
20 symbols with net change in reported shares from tracked managers.−11.4M−8.5M−5.7M−2.8M0.00Net change in reported shares (tracked managers)PFEMRKRVTYDHRBSXZTSABTAHCAJNJMASILLYPHGTMOMCKAZNWATGILDCORTCCRNSymbol

Frequently asked questions about Most sold healthcare stocks in Q1 2014

  • What are the most sold Healthcare stocks in Q1 2014?

    The most sold healthcare stocks in Q1 2014 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q4 2013, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2014?

    Among the managers we track, net reductions were largest in companies such as PFIZER INC (PFE), MERCK & CO. INC. (MRK), REVVITY INC (RVTY), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2013).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.